Table 3 Sample of errors contained within errata for COVID-19 therapeutics articles
Error type | Minor vs serious | Prior to correction | After correction |
|---|---|---|---|
Numerical/Statistical Error | Minor | Figure 1: 14 symptom onset > 3 days ago | Figure 1: 14 symptom onset > 7 days ago |
Author attribution/disclosure | Minor | Affiliation for single author “Humanitas Research Hospital, Milan, Italy” | Correct affiliation: “Department of Biomedical Sciences, Humanitas University, Milan, Italy, and IRCCS Humanitas Research Hospital, Milan, Italy” |
Interpretation error | Serious | “Results: There was severe adverse event recorded in the study group” | “Results: There was no severe adverse event recorded in the study group” |
Textual error | Minor | “The subsection 3.1, titled '3.1. Data are mean (SD). Day-1 indicates baseline measurements' is a misprint and should be omitted” | “The statement 'Data are mean (SD). Day-1 indicates baseline measurements' corresponds to the legend of Fig. 2 of the original article” |
Incorrect table/figure included | Minor | “Figures 3 and 4 were used twice due to a careless mistake during the preparation of Figures” | Correct Figures 3 and 4 now included in publication |
Citation error | Minor | “As it has been proposed in an influenza model of antiviral candidate drugs evaluation”, should omit the “25” in superindex | “As it has been proposed in an influenza model of antiviral candidate drugs evaluation” |
Other | Minor | Supplementary data file 1 containing anonymized patient data was inadvertently omitted | Supplementary data file 1 now included |